Evidence map›Paper›PMID 24263642›Full record

ArticleTherapeutic drug monitoring2013

Identifying methamphetamine exposure in children.

Marisol S Castaneto, Allan J Barnes, Karl B Scheidweiler, Michael Schaffer, Kristen K Rogers, Deborah Stewart, Marilyn A Huestis

Open access · greenAbstract readComparative Study
In one paragraph

Article in Therapeutic drug monitoring, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Findings of illicit drugs in hair of children at different ages.International journal of legal medicine · 2021
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Marisol S Castaneto*Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD; †Psychemedics Corporation, Culver City, CA; ‡Data, Benchmark and Evaluation Section, Maternal, Child and Adolescent Health Division, California Department of Public Health, Sacramento, CA; and §Student Health Service, California State University, Chico, CA.
Allan J Barnes
Karl B Scheidweiler
Michael Schaffer
Kristen K Rogers
Deborah Stewart
Marilyn A Huestis
National Institutes of Health · USCalifornia Department of Public Health · USNational Institute on Drug Abuse · US

Funding

Detection Of Drugs Of Abuse In Alternative Biological Fluids And TissuesZIADA000412 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI SCHEIDWEILER, KARL · 2009 to 2016
$3.9M
Detection Of Drugs Of Abuse In Biological Fluids/TissuesZ01DA000412 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HUESTIS, MARILYN · 1998 to 2008
$956k
Intramural NIH HHS Z01 DA000412Intramural NIH HHS Z99 DA999999Intramural NIH HHS ZIA DA000412
6 · The paper itself

Abstract

objectiveMethamphetamine (MAMP) use, distribution, and manufacture remain a serious public health and safety problem in the United States, and children environmentally exposed to MAMP face a myriad of developmental, social, and health risks, including severe abuse and neglect necessitating child protection involvement. It is recommended that drug-endangered children receive medical evaluation and care with documentation of overall physical and mental conditions and have urine drug testing. The primary aim of this study was to determine the best biological matrix to detect MAMP, amphetamine (AMP), methylenedioxymethamphetamine (MDMA), methylenedioxyamphetamine (MDA), and 3,4-methylenedioxyethylamphetamine (MDEA) in environmentally exposed children.

methodsNinety-one children, environmentally exposed to household MAMP intake, were medically evaluated at the Child and Adolescent Abuse Resource and Evaluation Diagnostic and Treatment Center at the University of California, Davis Children's Hospital. MAMP, AMP, MDMA, MDA, and MDEA were quantified in urine and oral fluid (OF) by gas chromatography mass spectrometry and in hair by liquid chromatography tandem mass spectrometry.

resultsOverall drug detection rates in OF, urine, and hair were 6.9%, 22.1%, and 77.8%, respectively. Seventy children (79%) tested positive for 1 or more drugs in 1 or more matrices. MAMP was the primary analyte detected in all 3 biological matrices. All positive OF (n = 5), and 18 of 19 positive urine specimens also had a positive hair test.

conclusionsHair analysis offered a more sensitive tool for identifying MAMP, AMP, and MDMA environmental exposure in children than urine or OF testing. A negative urine or hair test does not exclude the possibility of drug exposure, but hair testing provided the greatest sensitivity for identifying drug-exposed children.

Indexed as

AdolescentAmphetamine-Related DisordersAmphetaminesChildChild, PreschoolChromatography, LiquidEnvironmental ExposureGas Chromatography-Mass SpectrometryHairHumansInfantInfant, NewbornMethamphetamineSensitivity and SpecificitySubstance Abuse DetectionAmphetaminesMethamphetamine

Identifiers

PMID24263642
PMCPMC3838616
OpenAlexW2008744665

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.